Variant report

Variant	nsv907750
Chromosome Location	chr17:17439458-17460180
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:27)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:27 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:17444761..17447453-chr17:17453663..17455413,2	K562	blood:
2	chr17:17447456..17449744-chr17:17453079..17454836,2	K562	blood:
3	chr17:17460058..17461588-chr17:17463794..17465334,2	MCF-7	breast:
4	chr17:17451529..17456162-chr17:17456259..17460340,5	K562	blood:
5	chr17:17447456..17449744-chr17:17453079..17454836,2	K562	blood:
6	chr17:17439547..17441948-chr17:17448069..17450989,2	MCF-7	breast:
7	chr17:17434263..17436931-chr17:17447202..17448742,2	K562	blood:
8	chr17:17447568..17449636-chr17:17462055..17463779,2	MCF-7	breast:
9	chr17:17458257..17460886-chr17:17467700..17469221,2	K562	blood:
10	chr17:17451529..17456162-chr17:17456259..17460340,5	K562	blood:
11	chr17:17444761..17447453-chr17:17453663..17455413,2	K562	blood:
12	chr17:17398006..17400229-chr17:17440042..17442151,2	MCF-7	breast:
13	chr17:17432762..17434995-chr17:17447449..17449700,2	K562	blood:
14	chr17:17420339..17423033-chr17:17440049..17441973,2	MCF-7	breast:
15	chr17:17441533..17443885-chr17:17465004..17467167,2	K562	blood:
16	chr17:17437526..17439818-chr17:17494409..17495948,2	MCF-7	breast:
17	chr17:17415079..17418148-chr17:17445039..17448328,3	MCF-7	breast:
18	chr17:17456555..17458234-chr17:17467873..17470234,2	MCF-7	breast:
19	chr17:17398150..17401356-chr17:17456797..17458784,4	MCF-7	breast:
20	chr17:17449610..17452428-chr17:17454870..17458943,3	MCF-7	breast:
21	chr17:17439547..17441948-chr17:17448069..17450989,2	MCF-7	breast:
22	chr17:17440432..17443332-chr17:17443891..17446677,2	MCF-7	breast:
23	chr17:17398601..17400670-chr17:17453497..17457003,3	MCF-7	breast:
24	chr17:17449610..17452428-chr17:17454870..17458943,3	MCF-7	breast:
25	chr17:17453470..17455947-chr17:17461271..17462864,2	MCF-7	breast:
26	chr17:17440432..17443332-chr17:17443891..17446677,2	MCF-7	breast:
27	chr17:17407803..17409915-chr17:17438402..17440835,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RASD1-3	chr17:17452335-17454556	NONHSAT146095
2	lnc-RASD1-2	chr17:17447584-17449725	NONHSAT146094

No data

Variant related genes	Relation type
ENSG00000133027	chromatin interactions
ENSG00000264666	chromatin interactions
ENSG00000108551	chromatin interactions

Extended variants
information (count: 834 )
Associated
traits (count: 160 )

Variant overlapped rSNPs/rCNVs (count:834 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs750546	chr17:17439458-17439459	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs551971136	chr17:17439480-17439481	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs533988779	chr17:17439485-17439486	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs565794668	chr17:17439538-17439539	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs528088714	chr17:17439560-17439561	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs548247755	chr17:17439573-17439574	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs568320749	chr17:17439659-17439660	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs537342741	chr17:17439665-17439666	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs557088380	chr17:17439749-17439750	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs111493187	chr17:17439789-17439790	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs936108	chr17:17439793-17439794	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs144242598	chr17:17439795-17439796	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs558782405	chr17:17439839-17439840	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs572247562	chr17:17439887-17439888	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs79414243	chr17:17439888-17439889	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs554549817	chr17:17439988-17439989	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs570981740	chr17:17439999-17440000	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs147796443	chr17:17440008-17440009	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs184956019	chr17:17440027-17440028	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs564044964	chr17:17440057-17440058	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs577345284	chr17:17440058-17440059	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs546422619	chr17:17440082-17440083	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs188105978	chr17:17440106-17440107	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs148857113	chr17:17440111-17440112	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs548159483	chr17:17440191-17440192	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs73978968	chr17:17440267-17440268	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs530789835	chr17:17440268-17440269	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs550583874	chr17:17440305-17440306	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs570773338	chr17:17440309-17440310	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs539249486	chr17:17440340-17440341	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs533635861	chr17:17440364-17440365	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs180695376	chr17:17440391-17440392	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs546785356	chr17:17440431-17440432	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs565791104	chr17:17440432-17440433	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs368292000	chr17:17440482-17440483	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs4646395	chr17:17440516-17440517	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs141082652	chr17:17440544-17440545	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs574478328	chr17:17440556-17440557	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs537481991	chr17:17440588-17440589	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs4646394	chr17:17440595-17440596	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs145163819	chr17:17440606-17440607	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs546039854	chr17:17440610-17440611	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs559991494	chr17:17440713-17440714	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs572944069	chr17:17440760-17440761	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs535817992	chr17:17440773-17440774	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs541958580	chr17:17440810-17440811	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs7214152	chr17:17440823-17440824	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs114638289	chr17:17440829-17440830	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs34663545	chr17:17440831-17440832	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs371060903	chr17:17440861-17440862	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:160)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Breast cancer	21509527	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22543975	CNVD
Melanoma	22183965	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:518 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:17418200-17478000	Weak transcription	Primary T cells from cord blood	blood
2	chr17:17419600-17447000	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr17:17424600-17460000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
4	chr17:17427200-17440600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr17:17432000-17439600	Weak transcription	Fetal Intestine Small	intestine
6	chr17:17432600-17441200	Weak transcription	Ovary	ovary
7	chr17:17432800-17442600	Weak transcription	Spleen	Spleen
8	chr17:17433200-17439600	Weak transcription	Rectal Mucosa Donor 31	rectum
9	chr17:17434800-17448600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
10	chr17:17435000-17440600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr17:17436600-17441000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr17:17436600-17441600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
13	chr17:17436800-17479200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
14	chr17:17438600-17442800	Enhancers	Skeletal Muscle Female	skeletal muscle
15	chr17:17438600-17444800	Enhancers	Fetal Heart	heart
16	chr17:17438800-17440200	Enhancers	Breast Myoepithelial Primary Cells	Breast
17	chr17:17438800-17442000	Enhancers	A549	lung
18	chr17:17438800-17445200	Enhancers	Liver	Liver
19	chr17:17438800-17450800	Enhancers	Fetal Muscle Leg	muscle
20	chr17:17439000-17439800	Enhancers	Brain Anterior Caudate	brain
21	chr17:17439000-17440000	Enhancers	Colon Smooth Muscle	Colon
22	chr17:17439000-17440000	Enhancers	Fetal Brain Female	brain
23	chr17:17439000-17440000	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
24	chr17:17439000-17440000	Enhancers	HSMMtube	muscle
25	chr17:17439000-17440200	Enhancers	Muscle Satellite Cultured Cells	--
26	chr17:17439000-17440200	Enhancers	Psoas Muscle	Psoas
27	chr17:17439000-17440200	Enhancers	Rectal Smooth Muscle	rectum
28	chr17:17439000-17440200	Enhancers	Osteobl	bone
29	chr17:17439000-17440400	Enhancers	Cortex derived primary cultured neurospheres	brain
30	chr17:17439000-17440600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr17:17439200-17439600	Flanking Active TSS	Stomach Smooth Muscle	stomach
32	chr17:17439200-17439800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr17:17439200-17439800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
34	chr17:17439200-17439800	Enhancers	Brain Angular Gyrus	brain
35	chr17:17439200-17439800	Enhancers	Brain Cingulate Gyrus	brain
36	chr17:17439200-17439800	Enhancers	Brain Hippocampus Middle	brain
37	chr17:17439200-17439800	Enhancers	Brain Inferior Temporal Lobe	brain
38	chr17:17439200-17439800	Enhancers	HSMM	muscle
39	chr17:17439200-17440000	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr17:17439200-17440000	Enhancers	Adipose Nuclei	Adipose
41	chr17:17439200-17440000	Enhancers	Brain Substantia Nigra	brain
42	chr17:17439200-17440000	Enhancers	Duodenum Smooth Muscle	Duodenum
43	chr17:17439200-17440000	Enhancers	NHDF-Ad	bronchial
44	chr17:17439200-17440200	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr17:17439200-17440200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
46	chr17:17439200-17440600	Enhancers	Fetal Brain Male	brain
47	chr17:17439200-17440800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
48	chr17:17439200-17441200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
49	chr17:17439200-17441600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr17:17439200-17441600	Enhancers	Gastric	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links